Zurueck zur Suche

Reporte zur Charge U8058BA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

44Reporte angezeigt
1Todesfaelle
3Hospitalisiert
2Lebensbedrohlich
1Bleibende Schaeden
KY 9 TX 5 TN 3 OH 3 CA 3 PA 2 MN 2 CO 2 IL 2 NJ 1 SC 1 NV 1

VAERS 2715687

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8058BA

kritisch
Staat
-
Alter
59,0
Geschlecht
F
Eingang
20.11.2023
Impfdatum
19.10.2023
Beginn
12.11.2023
Tage bis Beginn
24,0
Dosis
N/A
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal distension Abdominal pain lower Abdominal tenderness Acute kidney injury Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Asthenia Auscultation Band neutrophil count Band neutrophil percentage Blood albumin decreased Blood alkaline phosphatase normal Blood bicarbonate decreased Blood bilirubin normal Blood calcium decreased Blood chloride decreased Blood creatinine increased

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 12, 2023 15:19 Verified By: MD on November 12, 2023 15:19 Encounter Info: Hospital, Inpatient, 11/12/23 - * Final Report * History of Present Illness/Subjective Patient is a 59-year-old female past history significant for hyperlipidemia, prediabetes, and anxiety with depression present emergency room with a 3-week history of watery diarrhea. Patient states she was in her normal state of health up until 3 weeks ago. She notes that time she had evidence of diarrhea. Initially was intermittent but loose. Over time the diarrhea became more watery and more regular with multiple voluminous diarrhea spells throughout the day. Over the last 2 weeks has become increasingly more weak. She has lost over 15 pounds as a result. She had some intermittent lower abdominal cramping. No symptoms of melena, bright blood per rectum or dark tarry stools. She denies any chest pain or shortness of breath. She has had several episodes of nausea as of late. In the last week has become increasingly more orthostatic with arising with positional changes. She been feeling progressively weakened. As result she presented to the walk-in clinic on the 10th where she was advised to hydrate and stool studies are pending. Over the last 48 hours her symptoms have worsened to the point that she had to come in for further evaluation due to weakness. Overall her symptoms have lasted approximately 3 weeks. She denies a fever or chills. No melena or bright red blood per rectum or tarry stools. She took Pepto-Bismol with only transient relief. She has not been on any antibiotics recently. She has not been around anybody who has been ill. Her daughter who had some loose stools for 3 days but this is since resolved. She does not work in healthcare. In the emergency room her blood pressure was 83/63, heart rate was as high as 151 bpm, respiratory rate as high as 34, temperature 36.8 with O2 sat 95% on room air. Serology: White count 23,200 with left shift hemoglobin 15.4 hematocrit 45.6 and a platelet count of 232,000. Sodium 132 potassium 3.9 chloride 97 bicarb 20 BUN 15 creatinine 1.71 and a blood sugar of 193. Calcium 8.5 alkaline phosphatase 52 ALT 12 AST 16 total bilirubin 0.9 total protein 6.2 albumin 3.4 lipase of 5 serum lactate 3.7. Stool sample positive for C. difficile. CT scan of the abdomen pelvis without contrast showed significant abnormal wall thickening and mucosal edema of the entire colon suggestive of pancolitis. A previously administered oral contrast media seen with no bowel obstruction and the small bowel segments were found to be unremarkable. COVID PCR pending Past medical history: Prediabetes, hyperlipidemia, autoimmune pulm cytopenia, anxiety and depression Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI. Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 36.8 ?C (Oral) BP: 94/70 HR: 121 (Monitored) HR: 121 (Peripheral) RR: 28 SpO2: 93% Oxygen Therapy: Nasal Cannula Oxygen Flow Rate: 2 (L/min) WT: 64.80 kg (WFC) Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 64.8 kg 11/12/23 Patient Height Current Height: 157.2 cm 11/12/23 General: Alert and oriented, No acute distress. Eye: Extraocular movements are intact, Vision unchanged HEENT: Normocephalic, Normal hearing Neck: Supple, Non-tender Respiratory: Lungs are clear to auscultation, Respirations are non-labored, Breath sounds are equal, No chest wall tenderness. Cardiovascular: Regular rate, Normal rhythm, No murmur, No gallop, Normal peripheral perfusion, Good pulses equal in all extremities, No edema. Gastrointestinal: Soft, diffuse bilateral abdominal tenderness, mildly distended, normal bowel sounds, no evidence of hepatosplenomegaly. Lymphatics: No lymphadenopathy neck Musculoskeletal: Normal range of motion, Normal strength Integumentary: Warm, Dry, No rash. Feet: Normal by visual exam, Normal pulses, Sensation intact. Neurologic: Alert, Oriented, Normal motor function Psychiatric: Cooperative, Appropriate mood & affect, Normal judgment. Assessment/Plan 1. Colitis due to Clostridium difficile A04.72 Patient presents with acute C. difficile pancolitis with secondary severe sepsis, orthostatic hypotension, dehydration, weight loss and precipitated SVT. Uncertain trigger this appears to be community-acquired C. difficile. She was started on oral vancomycin and IV Flagyl therapy. We will also start probiotic therapy. Given the volume of diarrhea soon we will start low-dose of Colestid to see if this helps improve her symptoms to help improve her dehydration. We will continue close monitoring of leukocytosis and volume status. Consider GI consultation if symptoms persist. 2. Diarrhea R19.7 As above. Work-up including culture pending at this time. 3. Severe sepsis R65.20 Patient feels criteria for severe sepsis with C. difficile being the source with pancolitis.IV fluid rehydration has been started. Sepsis bundle has been initiated. Culture data pending. IV fluid rehydration will be started with lactated Ringer's. She was placed on appropriate antibiotic therapy for C. difficile. 4. SVT (supraventricular tachycardia) I47.10 Patient 1 point presented with SVT. She came in tachycardic which increased. She has had intermittent tachycardia since she became dehydrated and over the last week or so. She was given a dose of adenosine. This is since resolved. She is currently has sinus tachycardia we will monitor this while hydrating. 5. Hypotension I95.9 Patient's profound hypotension with dehydration and orthostasis. She placed intensive care setting. We will be starting her on IV fluid rehydration and consider Levophed if symptoms persist or decline. She has evidence of hemoconcentration of her hemoglobin as well. 6. Renal insufficiency N28.9 Presenting now with acute kidney injury secondary to prerenal azotemia and dehydration likely associated from her C. difficile confounded by severe sepsis. We will continue IV fluid rehydration and monitor closely. If there is further decline we will ask nephrology to see her in consultation. 7. Prediabetes R73.03 Noted. A1c pending. We will not be initiating CDA protocol. We will continue to follow with daily testing. Carb controlled diet. 8. Anxiety and depression F41.9 Noted. Stable at this time. We will titrate in patient's home medication. 9. Autoimmune thrombocytopenia D69.3 Noted. Patient follows up with hematology. Currently under surveillance. Home medications were reviewed and appropriate medications ordered at this time. GI and DVT prophylaxis have been addressed. Total critical care time: Approximately 45 minutes?severe sepsis/C. difficile colitis/acute kidney injury/SVT Due to a high probability of clinically significant, life threatening deterioration, the patient required my highest level of preparedness to intervene emergently and I personally spent this critical care time directly and personally managing the patient. This critical care time included obtaining a history; examining the patient; pulse oximetry; ordering and review of studies; arranging urgent treatment with development of a management plan; evaluation of patient's response to treatment; frequent reassessment; and, discussions with other providers. This critical care time was performed to assess and manage the high probability of imminent, life-threatening deterioration that could result in multi-organ failure. It was exclusive of separately billable procedures and treating other patients and teaching time. Code Status None Recorded Chronic Problem List Anxiety and depression Autoimmune thrombocytopenia Colitis due to Clostridium difficile Diarrhea History of abnormal cervical Papanicolaou smear History of endometriosis History of neutropenia Hyperlipidemia Left hand pain Low hemoglobin Normal routine physical examination Osteoarthritis of carpometacarpal joint of left thumb Osteoarthritis of carpometacarpal joints of thumbs, bilateral Prediabetes Right carpal tunnel syndrome Right hand pain Routine health maintenance Severe sepsis Procedure/Surgical History ?LT Thumb CMCA w/FCR TT (09/06/2023) ?Carpal tunnel syndrome of right wrist (09/01/2019) ?colonoscopy (11/30/2017) ?Mammogram (12/15/2015) ?FOB - Fecal occult blood screening (11/19/2015) ?Ablation (11/04/2014) ?HPV typing (09/22/2014) ?Pap smear for cervical cancer screening.... (09/22/2014) ?Endometrial biopsy (09/23/2013) ?Screening for Chlamydia trachomatis (09/20/2013) ?Surgery (2000) ?Cesarean delivery (1987) ?TL - Tubal ligation (1987) ?Cesarean delivery (1986) Surgical History Internal 11/30/2017 Colonscpy Diagnostic/Screen MD Medications Home Medications (7) Active busPIRone 5 mg oral tablet 5 mg = 1 Tablet, Orally, TID Crestor 20 mg oral tablet 20 mg = 1 Tablet, Orally, QHS Estrace Vaginal Cream 0.1 mg/gm 1 GM, Vaginally, 2x/WK multivitamin 1 Tablet, Orally, Daily Unknown Med , Vitamin B12 Vitamin D3 (cholecalciferol) , Orally Zoloft 50 mg oral tablet 50 mg = 1 Tablet, Orally, Daily Active Scheduled Inpatient Medications None Reported One-Time Medications Given 11/11/23 00:00:00 TO 11/12/23 15:19:32 adenosine, Injection, 6 mg, IV Push, ONCE, (1 DOSE 11/12/23 12:27:00) Cipro, Infusion, 400 mg, IVPB, ONCE, (1 DOSE 11/12/23 11:39:00) fentaNYL, Injection, 50 mCg, IV Push, ONCE, (1 DOSE 11/12/23 10:13:00) Flagyl, Infusion, 500 mg, IVPB, ONCE, (1 DOSE 11/12/23 11:41:00) ondansetron, Injection, 4 mg, IV Push, ONCE, prn, Nausea/Vomiting IV - Use First, (1 DOSE 11/12/23 10:13:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 500 mL, IVPB, ONCE, (1 DOSE 11/12/23 10:36:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 11/12/23 10:36:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 500 mL, IVPB, ONCE, (1 DOSE 11/12/23 12:15:00) vancomycin (vancomycin 125 mg oral capsule), Capsule, 125 mg, Orally, ONCE, (1 DOSE 11/12/23 12:38:00) PRN Medications (0600 - 0559) from 11/11 - 11/12 fentaNYL, 50 mCg, IV Push, Q10min, 0 Dose(s) Allergies Robitussin (diff breathing, hives) codeine (mood swings) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Employment/School Employed, Work/School description: Exercise Exercise type: Walking. Home/Environment Moved in with boyfriend recently (He had a stroke), Lives with Significant other. Feels unsafe at home: No. Nutrition/Health Diet: Regular. Caffeine intake amount: Tea, soda. Sexual Sexually active: Yes. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Breast cancer: Grandmother (M) (Dx at 50). Cancer of lung...: Grandfather (M). Cervical dysplasia: Sister. Diabetes mellitus type 2: Father and Sister. Endometriosis: Mother. Heart disease..: Father. Hyperlipidemia..: Father and Sister. Hypertension..: Mother. Myocardial infarction...: Father. Stroke: Sister. Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 23.2 k/cumm High (11/12/23 10:07:00) RBC: 5.12 million/cumm (11/12/23 10:07:00) Hgb: 15.4 GM/dL High (11/12/23 10:07:00) Hct: 45.6 % (11/12/23 10:07:00) MCV: 89 fL (11/12/23 10:07:00) MCH: 30 pg (11/12/23 10:07:00) MCHC: 33.7 GM/dL (11/12/23 10:07:00) RDW: 13.8 % (11/12/23 10:07:00) Platelet: 232 k/cumm (11/12/23 10:07:00) MPV: 8.7 fL (11/12/23 10:07:00) Band: 13 % (11/12/23 10:07:00) Neutrophil: 67 % (11/12/23 10:07:00) Lymphocyte: 10 % (11/12/23 10:07:00) Monocyte: 10 % (11/12/23 10:07:00) Absolute Band: 3 k/cumm High (11/12/23 10:07:00) Absolute Neutrophil: 15.4 k/cumm High (11/12/23 10:07:00) Abs Lymphocyte: 2.3 k/cumm (11/12/23 10:07:00) Absolute Monocyte: 2.3 k/cumm High (11/12/23 10:07:00) RBC Morphology: See description UC (11/12/23 10:07:00) Polychromasia: Slight. (11/12/23 10:07:00) Schistocyte: Few (1+). (11/12/23 10:07:00) Platelet Estimate: Adequate. (11/12/23 10:07:00) Platelet Morphology: See Comment. (11/12/23 10:07:00) Chemistry: Sodium SerPl QN: 132 mmol/L Low (11/12/23 10:07:00) Potassium SerPl QN: 3.9 mmol/L (11/12/23 10:07:00) Chloride SerPl QN: 97 mmol/L Low (11/12/23 10:07:00) Carbon Dioxide SerPl QN: 20 mmol/L Low (11/12/23 10:07:00) Anion Gap: 15 mmol/L High (11/12/23 10:07:00) BUN SerPl QN: 18 mg/dL (11/12/23 10:07:00) Creatinine SerPl QN: 1.71 mg/dL High (11/12/23 10:07:00) Estimated GFR (CKD-EPI, no race): 34 mL/min/1.73m2 Low (11/12/23 10:07:00) Estimated CRCL (CG): 31 mL/min Low (11/12/23 10:07:00) Glucose SerPl QN: 193 mg/dL High (11/12/23 10:07:00) Calcium Total SerPl QN: 8.5 mg/dL (11/12/23 10:07:00) Alkaline Phos SerPl QN: 52 Units/L (11/12/23 10:07:00) ALT SerPl QN: 12 Units/L (11/12/23 10:07:00) AST SerPl QN: 16 Units/L (11/12/23 10:07:00) Bilirubin Total SerPl QN: 0.9 mg/dL (11/12/23 10:07:00) Total Protein SerPl QN: 6.2 GM/dL Low (11/12/23 10:07:00) Albumin SerPl QN: 3.4 GM/dL Low (11/12/23 10:07:00) Lipase SerPl QN: 5 Units/L Low (11/12/23 10:07:00) Lactate Venous Pl QN: 3.7 mmol/L High (11/12/23 10:07:00) Anion Gap, POC: 20 mmol/L (11/12/23 10:14:00) CO2, POC: 19 mmol/L Low (11/12/23 10:14:00) BUN, POC: 16 mg/dL (11/12/23 10:14:00) Chloride, POC: 97 mmol/L Low (11/12/23 10:14:00) Creatinine, POC: 1.7 mg/dL High (11/12/23 10:14:00) Glucose, POC: 199 mg/dL High (11/12/23 10:14:00) Potassium, POC: 3.7 mmol/L (11/12/23 10:14:00) Sodium, POC: 131 mmol/L Low (11/12/23 10:14:00) Estimated CRCL (CG), POC: 31 mL/min Low (11/12/23 10:14:00) Estimated GFR (CKD-EPI, no race), POC: 34 mL/min/1.73m2 Low (11/12/23 10:14:00) All Other Labs: Stool Sample Consistency: Unformed Stool (11/12/23 11:30:00) C diff Algorithm Interp: See Comment (11/12/23 11:30:00) C diff Assay EIA Interp: Positive Abnormal (11/12/23 11:30:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/12/2023 13:24 - CT Abd/Pelvis W/O IV Contrast IMPRESSION:Significant abnormal wall thickening and mucosal edema of the entirecolon suggestive of pancolitis. A previously administered oralcontrast media seen. No bowel obstruction. Small bowel segments areunremarkable.Thank you for consulting our team of subspecialty radiologists. Please contact us at with any questions. Signature Line Electronically Signed on 11/12/23 15:19 ________________________________________________________ MD

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2687879

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

kritisch
Staat
CO
Alter
63,0
Geschlecht
F
Eingang
28.09.2023
Impfdatum
18.09.2023
Beginn
23.09.2023
Tage bis Beginn
5,0
Dosis
N/A
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Pyrexia

Symptomtext

Per patient's husband, approximately five days after receiving the Flublok vaccine, patient began running a fever the night of 9/23. Patient then passed away in her sleep.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None noted in profile
Vorgeschichte
None noted in profile
Andere Medikamente
Bisoprolol, ropinirole, oxybutynin, meloxicam
Allergien
None noted in profile
Vorherige Impfungen
-

VAERS 2718310

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge U8058BA

schwer
Staat
MN
Alter
87,0
Geschlecht
M
Eingang
28.11.2023
Impfdatum
10.10.2023
Beginn
01.11.2023
Tage bis Beginn
22,0
Dosis
7+
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Angiogram cerebral Arteriogram carotid Blood lactic acid normal Blood thyroid stimulating hormone normal C-reactive protein normal Computerised tomogram head Full blood count normal Guillain-Barre syndrome Immunoglobulin therapy Magnetic resonance imaging spinal Metabolic function test Muscular weakness Musculoskeletal disorder Red blood cell sedimentation rate increased Ultrasound Doppler Upper respiratory tract infection Vitamin B12 normal X-ray limb abnormal

Symptomtext

Influenza and Covid vaccine administered on 10/10/23. Patient seen in express clinic for upper respiratory infection on 10/18/23 and treated with azithromycin. RSV vaccine administered on 10/24/23. Patient seen in clinic for bilateral leg weakness on 11/15/23 that started three days prior. Patient seen in emergency department on 11/18/23 for progressive bilateral leg weakness and failure. Patient admitted to hospital that day with a diagnosis of Guillain- barre syndrome and treated with intravenous immunoglobulin 0.4 g/kg/day x 5 days. Progressive nature of leg weakness ceased after day 1 of IVIG therapy, and gradual return of leg function started to return around day 3 or 4 of therapy. Patient discharged to skilled nursing facility to continue PT/OT as he is not back at his baseline strength as of the time of this report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
9,0
Labordaten
imaging: 11/15 hip x-ray; 11/18 foot/oblique xray; 11/19: Brain CT; 11/19 MRI lumbar, thoracic and cervial spine; 11/21 MRI angiogram brain/neck; 11/28 leg ultrasound 11/15/23: elevated ESR (53), CRP, CBC and BMP all within normal limits 11/18/23: ESR (37), B12, TSH, lactate, CRP all within normal limits 11/19/23: ESR (33)
Aktuelle Erkrankungen
respiratory illness between COVID/flu vaccine on 10/10/23 and RSV vaccine on 10/24/23
Vorgeschichte
A Fib, diastolic HF
Andere Medikamente
allopurinol, furosemide, metoprolol, warfarin
Allergien
statin intollerance
Vorherige Impfungen
-

VAERS 2677020

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

schwer
Staat
FL
Alter
36,0
Geschlecht
F
Eingang
27.08.2023
Impfdatum
26.08.2023
Beginn
26.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Dizziness Electrocardiogram normal Hypotension Nausea Syncope

Symptomtext

Patient started feeling dizzy after the administration of 4 out of 5 vaccines scheduled. After a couple of seconds he fainted for a couple of seconds. She was still very dizzy and nauseous and her blood pressure was very low. Since patient was not recovering the paramedics were called. They performed further test and when stable she agreed to go to the hospital for further testing with them and her husband.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
8/26/2023 BP: 1.78.48 2.83/54.3 99/68 8/26/2023 BS: 78 8/26/2023 ECG Normal
Aktuelle Erkrankungen
Non
Vorgeschichte
Non
Andere Medikamente
Non
Allergien
Rocephin
Vorherige Impfungen
-

VAERS 2722484

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

moderat
Staat
WA
Alter
60,0
Geschlecht
F
Eingang
12.12.2023
Impfdatum
08.10.2023
Beginn
01.10.2023
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Pain Sleep disorder Loss of personal independence in daily activities Mobility decreased Pain in extremity Tenderness

Symptomtext

No idea on manufacturer as no paperwork or info was given. Pharmacist was obviously having a bad day, seemed rushed and complained about being short staffed. I received one shot in my left arm ( the RSV) and two in my right, the flu and covid. I am left handed. I do recall one bandage per arm. Some tenderness, which was to be expected, but lingering pain, discomfort and pain with movement of right arm ( hard to take clothes on and off, pain wakes me at night when I move my arm a certain way). Tried Tylenol, heat, various balms etc. Still hurts and limited movement after two months plus.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
None yet. Reported incident to the pharmacy last week, as well as my own doctor ( but she has not seen me for it yet) as well as one other pharmacy ( my usual one) and he said I should report this.
Aktuelle Erkrankungen
Covid in September- mild
Vorgeschichte
Diabetic, benign essential tremor
Andere Medikamente
Metformin, Progesterone, Ozempic, Vagifem, Vit D3, Vit B12, Felodipine, Tylenol PM, Melatonin, Estradiol, Gabapentin, ALA
Allergien
IV contrast, mold, smoke Cannot find list of medications I am unable to take. Dr. can provide if needed
Vorherige Impfungen
-

VAERS 2693244

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

moderat
Staat
MI
Alter
49,0
Geschlecht
F
Eingang
09.10.2023
Impfdatum
08.10.2023
Beginn
08.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling hot Immediate post-injection reaction Mobility decreased

Symptomtext

immediately after receiving flublok pt felt extreme heat radiating down her arm from shoulder to hand as if a nerve was hit. was having difficulty raising her arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2684514

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8058BA

moderat
Staat
IL
Alter
63,0
Geschlecht
F
Eingang
21.09.2023
Impfdatum
20.09.2023
Beginn
21.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site warmth Paraesthesia

Symptomtext

Teammate states left arm with tingling from shoulder to wrist. Has red, warm and raised area the size of her fist around the injection site and redness goes up shoulder and down to elbow. States has had this type of reaction in previous years after her flu vaccine, symptoms usually go away after about 3 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
See above

VAERS 2680790

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

moderat
Staat
NV
Alter
78,0
Geschlecht
F
Eingang
09.09.2023
Impfdatum
05.09.2023
Beginn
06.09.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Tremor

Symptomtext

PT TOOK CARE OF HUSBAND HAVING REACTIONS TO VACCINES DEALING WITH EMT AND THRE ER. WHEN SHE GOT HOME AT MIDNIGHT, SHE STARTED HAVING THE SHAKES AND CHILLS THAT LASTED HALF HOUR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
UNKNOWN
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
NO KNOWN DRUG ALLERGIES
Vorherige Impfungen
-

VAERS 2714061

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

mild
Staat
NJ
Alter
64,0
Geschlecht
F
Eingang
15.11.2023
Impfdatum
11.10.2023
Beginn
11.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Oral herpes Rash Swelling Swelling face

Symptomtext

rash above my upper lip, rash on my face, fever blisters on both lips, swelling of the face and neck, lasting for weeks. I am still experiencing minimal effects of the Vaccination after almost 5 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
N/A
Allergien
eggs
Vorherige Impfungen
-

VAERS 2709172

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

mild
Staat
TX
Alter
78,0
Geschlecht
F
Eingang
02.11.2023
Impfdatum
02.11.2023
Beginn
02.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Crying Immediate post-injection reaction Incorrect dose administered Injection site pain Pain Underdose

Symptomtext

The patient stated that she had an adverse reaction to the Fluzone HD she received last year. She reported pain, redness, swelling, itching, and a red rash at the injection site on her left arm that persisted for over 6 months. She stated she still wanted to receive a flu shot this year despite her previous adverse reaction. I counseled her on her options, and risk of cross-reaction, and the patient agreed to receive FluBlok to see if she tolerated this formulation. I also recommended that the injection be placed into her right arm due to previous reaction in her left arm. The patient refused the recommendation and insisted that she receive the FluBlok injection into her left arm. Immediately upon injection into the left deltoid, the patient cried out and stated she was in terrible "excruciating" pain. Approximately half of the pre-filled syringe (about 0.25 ml) was injected into the middle of the patient's left deltoid before the needle was removed. The patient stated that her arm continued to hurt at the injection site for a few minutes, and then the pain subsided and that she was "ok". She refused to receive the other 0.25 ml remaining in the prefilled syringe. Upon visual and tactile inspection of the injection site no visible or palpable abnormalities were observed. No redness, swelling, bruising, or discoloration was noted. The patient did not report any numbness of the left arm, she stated that her pain had subsided, and that she still had full function of her left arm. The patient was advised to notify her PCP of the atypical reaction and for advice on how to proceed since she only received half of her flu vaccine. I also advised her to receive any subsequent vaccines in her right arm. The patient was notified that we are available at the pharmacy 24 hours/day and to contact us if any further issues/reactions occurred or with any questions or concerns. The patient understood.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
Pain, redness, swelling, itching, and rash at injection site that persisted for over 6 months after receiving Fluzone HD. Pt age

VAERS 2703724

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

mild
Staat
MN
Alter
56,0
Geschlecht
M
Eingang
27.10.2023
Impfdatum
27.10.2023
Beginn
27.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia Hyperhidrosis Injection site reaction Pyrexia Rash

Symptomtext

Rash, Fever, weakness, sweating at site. Erratic vitals. Treating with tylenol and bringing to ER for evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689481

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

mild
Staat
SC
Alter
12,0
Geschlecht
M
Eingang
02.10.2023
Impfdatum
30.09.2023
Beginn
30.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Product administered to patient of inappropriate age

Symptomtext

Patient is 12 years old and was given Flublok which is recommended for 18 and over. Spoke with the mom on 10/2 and she stated he had a headache afterwards, but wasn't sure if that was related to the vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689417

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

mild
Staat
TX
Alter
22,0
Geschlecht
F
Eingang
02.10.2023
Impfdatum
02.10.2023
Beginn
02.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

After administering the vaccine the patient stated she felt a little light headed and sat down on the floor. Then she slumped side ways into a fetal position and stated she felt like she was going to pass out. The patient never lost consciousness and rested in the fetal position for about 5 minutes. Then sat up and had some cracker and Gatorade. The patient felt better, waited in the waiting room chair for another 5 to 10 minutes then left.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No known allergies
Vorherige Impfungen
Felt faint on vaccination with meningitis

VAERS 2689029

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

mild
Staat
TX
Alter
23,0
Geschlecht
F
Eingang
30.09.2023
Impfdatum
30.09.2023
Beginn
01.09.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fall Head injury Pallor Vomiting

Symptomtext

Patient requested both vaccines in one arm (left). Administered the vaccinations, within seconds the patient leaned into her boyfriend sitting adjacent. Given the patients young age and jovial manner, I thought she was being affectionate but, the patient soon slipped from the chair and hit her head on the floor. Patient quickly regained consciousness, was helped to the chair, was pale and began to vomit soon thereafter. Called emergency services which arrived within minutes. Patient was hesitant to go with the EMT but after I suggested she go, she did. Before the EMTs arrived the patient expressed some embarrassment as she had never fainted after a vaccination prior to this event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vomiting
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
mitral valve prolapse- known and monitored by physician but, not treated with medication
Vorgeschichte
mitral valve prolapse- known and monitored by physician but, not treated with medication
Andere Medikamente
escitalopram
Allergien
peanuts
Vorherige Impfungen
-

VAERS 2687851

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

mild
Staat
TN
Alter
61,0
Geschlecht
F
Eingang
28.09.2023
Impfdatum
25.09.2023
Beginn
28.09.2023
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site swelling

Symptomtext

red raised itchy site reported by phone from patient that started a couple of hours after IMZ

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2687674

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

mild
Staat
-
Alter
42,0
Geschlecht
F
Eingang
27.09.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Hyperhidrosis Nausea Pallor

Symptomtext

Pt reported feeling lightheaded and nauseous after vaccination. Recorded BP and BP was in normal range. Pt was pallor and sweating. After resting for ~5 minutes and drinking water, pt felt better. Monitored patient for 30 minutes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2686601

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

mild
Staat
CA
Alter
30,0
Geschlecht
F
Eingang
26.09.2023
Impfdatum
26.09.2023
Beginn
26.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity Peripheral swelling

Symptomtext

Pt reported swollen and red painful arm. Potentially also might have a fever. Onset of symptoms was approximately a day after the vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2685252

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

mild
Staat
UT
Alter
19,0
Geschlecht
F
Eingang
22.09.2023
Impfdatum
13.09.2023
Beginn
18.09.2023
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
CSF culture negative CSF glucose decreased CSF white blood cell differential Headache Meningitis bacterial Musculoskeletal stiffness Neutrophil percentage increased Pyrexia

Symptomtext

Patient developed signs and symptoms of meningitis with classic triad of fevers, headache, and neck stiffness. Patient was treated for bacterial meningitis with IV antibiotics. The patient's condition improved over the course and was able to be discharged back to home to complete course of IV antibiotics.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
5,0
Labordaten
Lumbar puncture CSF significant for glucose: 33 neutrophil 58%. CSF cultures never grew any identifiable organisms. Unclear if related to recent vaccination.
Aktuelle Erkrankungen
Migraines
Vorgeschichte
none
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2721777

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
17,0
Geschlecht
F
Eingang
07.12.2023
Impfdatum
24.11.2023
Beginn
01.11.2023
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

N/A

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2715188

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
CA
Alter
82,0
Geschlecht
M
Eingang
17.11.2023
Impfdatum
15.11.2023
Beginn
17.11.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Haematochezia

Symptomtext

Patient experiencing blood in stool with no other symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Haematochezia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682794

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
13,0
Geschlecht
F
Eingang
16.11.2023
Impfdatum
16.09.2023
Beginn
16.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Incorrect vaccine given per age

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
No
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 2712651

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
AZ
Alter
15,0
Geschlecht
F
Eingang
10.11.2023
Impfdatum
25.09.2023
Beginn
28.09.2023
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product administered to patient of inappropriate age

Symptomtext

Adverse Event- Flublok vaccine administered to 15 yo female patient. Treatment: none Outcome: No serious adverse outcome. Guardian notified of medication error on 10/5/23 when provider notified of medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
3 days later after flu vaccine, patient received a covid vaccine. 4 days later after flu vaccine, patient developed nasal drainage and cough.
Allergien
unknown
Vorherige Impfungen
-

VAERS 2712343

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
VA
Alter
17,0
Geschlecht
F
Eingang
10.11.2023
Impfdatum
06.11.2023
Beginn
01.11.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

incorrect vaccine administered

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2710187

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
17,0
Geschlecht
F
Eingang
06.11.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

NONE- PATIENT IS 17 YEARS OLD AND WAS ADMINISTERED FLUBLOK THAT IS INDICATED FOR PATIENTS 18 AND UP. PATIENT TOLERATED VACCINE WELL AND HAS NOT HAD ANY ADVERSE EVENTS OR REACTIONS

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2701647

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
IL
Alter
60,0
Geschlecht
F
Eingang
25.10.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient was administered an Influenza Vaccine, after she already received one a week prior.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2697839

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
IN
Alter
14,0
Geschlecht
F
Eingang
18.10.2023
Impfdatum
17.09.2023
Beginn
17.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

She was given the wrong flu shot for her age group. We have tried contacting the family to see if there were any adverse reactions but have not been able to reach them.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
none that I'm aware of
Vorgeschichte
acid reflux
Andere Medikamente
none
Allergien
strawberries and shellfish
Vorherige Impfungen
-

VAERS 2697019

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
15,0
Geschlecht
M
Eingang
17.10.2023
Impfdatum
06.10.2023
Beginn
06.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Pt received Flublok recommened for 18 years and older. Pt is age 15 years old. Mother states pt reacted fine to vacccine. No adverse side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2696025

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
TN
Alter
55,0
Geschlecht
F
Eingang
14.10.2023
Impfdatum
06.10.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymphadenopathy

Symptomtext

swollen lymph nodes under the left arm; Initial information received on 09-Oct-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 55 years old female patient who experienced swollen lymph nodes under the left arm after receiving Influenza Quadrivalent Recombinant Vaccine [Flublok Qiv]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 06-Oct-2023, the patient received 0.5 ml of suspect Influenza Quadrivalent Recombinant Vaccine (Frequency: once, Strength: Standard) (lot number: U8058BA) (with an unknown expiry date) via intramuscular route in the left deltoid for immunization. On an unknown date, the patient developed swollen lymph nodes under the left arm (lymphadenopathy) (unknown latency). It was reported, Call received from pharmacist reporting a patient who received a dose of FLUBLOK QIV, on Friday, 06OCT2023, called to report she is experiencing swollen lymph nodes under the left arm. Patient called pharmacy today, 09OCT2023, stating that she noticed the swollen lymph nodes after she exercised, denies any other symptoms. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event (swollen lymph nodes under the left arm). At time of reporting, the outcome was Not Recovered / Not Resolved for the event swollen lymph nodes under the left arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymphadenopathy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2692541

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
TX
Alter
40,0
Geschlecht
F
Eingang
08.10.2023
Impfdatum
05.10.2023
Beginn
05.10.2023
Tage bis Beginn
0,0
Dosis
7+
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
VITAMINS
Allergien
NONE
Vorherige Impfungen
-

VAERS 2692541

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
TX
Alter
40,0
Geschlecht
F
Eingang
08.10.2023
Impfdatum
05.10.2023
Beginn
05.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

NONE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
VITAMINS
Allergien
NONE
Vorherige Impfungen
-

VAERS 2692327

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
17,0
Geschlecht
M
Eingang
06.10.2023
Impfdatum
02.10.2023
Beginn
02.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Gave flublok to 17 year old when only approved for 18 years and older. No symptoms or side effects known.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
None
Vorherige Impfungen
-

VAERS 2690010

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
CA
Alter
24,0
Geschlecht
F
Eingang
03.10.2023
Impfdatum
03.10.2023
Beginn
03.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pallor Pulse abnormal

Symptomtext

PATIENT STARTED WAVERING IN HER CHAIR AFTER I ADMINISTERED THE SECOND SHOT (FLU SHOT). I NOTICED HER EYES WERE CLOSED. I GRABBED HER SHOULDERS AND CALLED HER NAME. SHE NEVER FELL AND AFTER A FEW MINUTES WAS AWAKE. I HAD HER LAY DOWN AND TOOK HER BLOOD PRESSURE. IT WAS NORMAL. PULSE WAS VERY WEAK AND HER LIPS WERE PALE. SHE FELT BETTER AFTER LYING DOWN AND SHE ASKED FOR SOME WATER. SHE WAS ABLE TO LEAVE ON HER OWN ABOUT 10-15MINS LATER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pallor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689153

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
13,0
Geschlecht
M
Eingang
01.10.2023
Impfdatum
30.09.2023
Beginn
30.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Flubok flu vaccine was administered to a person less than 18 years old. Pt should have received an age appropriate vaccine like Fluzone instead.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689150

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
14,0
Geschlecht
M
Eingang
01.10.2023
Impfdatum
30.09.2023
Beginn
30.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Flublok flu vaccine was given to a patient less than 18 years of age. He should have received an age appropriate vaccine like Fluzone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2688976

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

gering
Staat
OH
Alter
64,0
Geschlecht
F
Eingang
30.09.2023
Impfdatum
30.09.2023
Beginn
30.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient received a flu vaccine beginning of September. I did not realize until after she got her second flu vaccine. Patient was called and notified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
no
Vorherige Impfungen
-

VAERS 2684862

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
PA
Alter
68,0
Geschlecht
F
Eingang
21.09.2023
Impfdatum
12.09.2023
Beginn
12.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered

Symptomtext

FLUBLOK QIV was administered to patient post excursion with no reported adverse event; Initial information received on 15-Sep-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 68 years old female patient to whom administered the Influenza Quadrivalent Recombinant Vaccine [Flublok Qiv] after post excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Sep-2023, the patient received a dose of 0.5 ml of suspect Influenza Quadrivalent Recombinant Vaccine after excursion(strength: standard, frequency: once, expiry date: 31-May-2025 and lot U8058BA) via intramuscular route in the deltoid nos as immunization (poor quality product administered) (latency: same day). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA284375:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2684861

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
PA
Alter
60,0
Geschlecht
M
Eingang
21.09.2023
Impfdatum
12.09.2023
Beginn
12.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

administering FLUBLOK QIV post excursion of 30.4F with no reported adverse event; Initial information received on 15-Sep-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 60-years-old male patient who was administered influenza quadrivalent recombinant vaccine [Flublok QIV] post excursion of 30.4 f with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Sep-2023, the patient received 0.5 mL dose of suspect influenza quadrivalent recombinant vaccine (formulation unknown) (Strength: Standard; Frequency: Once) (batch number: U8058BA; expiry date: 31-May-2024) via intramuscular route in the deltoid nos (not otherwise specified) for Immunization, post excursion of 30.4f with no reported adverse event (poor quality product administered) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. No additional information at the time of call, caller declined follow-up. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2023SA284378:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2684052

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
OH
Alter
17,0
Geschlecht
F
Eingang
20.09.2023
Impfdatum
07.09.2023
Beginn
07.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Flublok given to patient <18 years old

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2683332

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
NY
Alter
2,0
Geschlecht
F
Eingang
18.09.2023
Impfdatum
11.09.2023
Beginn
11.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

2 year old received flublok quadrivalent today with no reported adverse event; Initial information received on 13-Sep-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 2 years old female patient who received influenza quadrivalent recombinant vaccine [Flublok QIV] today with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 11-Sep-2023, the patient received 0.5 ml dose (once) of suspect influenza quadrivalent recombinant vaccine, (lot U8058BA: expiray date: 31-May-2024) (formulation, strength not reported) via intramuscular route in the left thigh for Immunization with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). Action taken: not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682850

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

gering
Staat
OH
Alter
14,0
Geschlecht
M
Eingang
17.09.2023
Impfdatum
17.09.2023
Beginn
-
Tage bis Beginn
-
Dosis
N/A
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

We processed a prescription for Fluzone Quad but then administered Flublok Quad.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2682796

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
KY
Alter
17,0
Geschlecht
M
Eingang
16.09.2023
Impfdatum
16.09.2023
Beginn
01.09.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient was given Flublok that should have only been given to patient 18 years or older. Patient had no adverse reactions to vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2682386

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge u8058ba

gering
Staat
KY
Alter
70,0
Geschlecht
F
Eingang
15.09.2023
Impfdatum
14.09.2023
Beginn
14.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dysphagia Swollen tongue

Symptomtext

Patient received vaccine approximately 11:05am, returned to clinic at 12:30 complaining of tongue feeling swollen and difficulty swallowing. Patient evaluated, no abnormal findings, instructed to take Benadryl and follow up with ER/CALL EMS for emergent worsening symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dysphagia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2680905

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U8058BA

gering
Staat
TN
Alter
17,0
Geschlecht
F
Eingang
11.09.2023
Impfdatum
01.09.2023
Beginn
01.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Flublok given to 17 year old

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2679747

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge U8058BA

gering
Staat
CO
Alter
16,0
Geschlecht
M
Eingang
06.09.2023
Impfdatum
25.08.2023
Beginn
25.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

Administered vaccine for 18 year and above to a 16 year old male. Patient has not report any adverse reaction as of today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-